OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 50 filers reported holding OVID THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,000 | – | 229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,252,892 | $10,930,000 | 4.97% |
| GLOBEFLEX CAPITAL L P | 1,397,770 | $4,697,000 | 1.02% |
| BVF INC/IL | 6,631,051 | $22,280,000 | 0.87% |
| EcoR1 Capital, LLC | 6,082,200 | $20,436,000 | 0.71% |
| Ikarian Capital, LLC | 1,105,082 | $3,715,000 | 0.26% |
| CHI Advisors LLC | 233,510 | $785,000 | 0.23% |
| DCF Advisers, LLC | 141,701 | $476,000 | 0.21% |
| Artal Group S.A. | 2,500,000 | $8,400,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,577,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 1,903,162 | $6,394,000 | 0.02% |